Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ALKS 37 in Opioid-Induced Constipation
NCT01382797Phase 2Completed
- Sponsor
- Alkermes
- Start
- Aug 2011
- Primary completion
- Apr 2012
- Countries
- 1
01
Overview
A Phase 2 trial of methylsamidorphan in opioid-induced constipation (OIC), sponsored by Alkermes. Started Aug 2011; status: completed.
02
Drugs
methylsamidorphan
03
Conditions
opioid-induced constipation (OIC)
Beyond the preview
Go deeper on NCT01382797.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01382797.